CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2026.06.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Jinjian Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Provincial Clinical Research Center for Rheumatic and…. Hauptthemen laut MEDLINE: Antigens, CD19, Lupus Erythematosus, Systemic, Immunotherapy, Adoptive, Central Nervous System. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVES: Autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy shows promise for refractory systemic lupus erythematosus (SLE), but its impact on central nervous system (CNS) immune remodelling and the cellular features associated with CAR-T-associated neurotoxicity remains unclear. METHODS: We performed integrated single‑cell RNA/T-cell receptor (TCR) sequencing and Olink proteomics on cerebrospinal fluid (CSF) from patients with SLE treated longitudinally with CAR‑T therapy (baseline n = 2, D9 n = 4, D60 n = 5), plus independent baseline single-cell RNA sequencing (n = 2) and Olink samples (n = 3). RESULTS: Single-cell profiling of 47,222 CSF cells showed dynamic CNS immune composition following CAR-T therapy, with notable changes in T cells. CAR-T cells were detected in the CNS and displayed predominantly proliferative and cytotoxic states at D9, whereas memory- and exhaustion-associated states predominated at D60. Endogenous CD8⁺ T cells exhibited diverse effector subsets at day 9, including granzyme B (GZMB)⁺, natural killer-like, type I interferon (IFN)-responsive, and human leukocyte antigen (HLA)⁺ granzyme H (GZMH)⁺ populations, followed by predominance of memory and proliferating subsets at day 60. CD4⁺ T cells at day 9 were enriched for type I IFN signalling. Ligand-receptor analysis showed extensive interactions between myeloid populations and lymphocytes. TCR analysis showed changes in clonal diversity and dynamics following treatment. CONCLUSIONS: These findings suggest an association between CAR-T therapy and CNS immune remodelling in SLE, and provide cellular and molecular observations that may inform future studies of CNS immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Provincial Clinical Research Center for Rheumatic and Immunologic Diseases, Xiangya Hospital, Central South University, Cha…
- Department of Bioinformatics, Hunan Agricultural University, Changsha, Hunan, China.
- JW Therapeutics (Shanghai) Co Ltd, Shanghai, China.
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: chenxiangck@csu.edu.cn.
Förderung
- Hunan Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Sun, J., Hu, X., Li, W., Tian, Z., Xiao, S., Li, W., Xie, C., Xia, P., Xia, Z., Chen, X., Luo, H., Zhao, H., & Tian, Y. (2026). CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.06.030
Vancouver
Sun J, Hu X, Li W, Tian Z, Xiao S, Li W, et al. CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.06.030
BibTeX
@article{Sun2026,
author = {Sun, Jinjian and Hu, Xiaoru and Li, Weina and Tian, Zuge and Xiao, Shouli and Li, Wanhan and Xie, Cuiwei and Xia, Peng and Xia, Zhen and Chen, Xiang and Luo, Hui and Zhao, Hongjun and Tian, Yuzi},
title = {CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2026.06.030}
}
EUVIMED